Named on one round in the feed.
Since 2025-12-05
ROUNDS
1
joined, none as lead
ROUNDS JOINED · USD
$100M
across 1 round
CO-INVESTORS
3
named beside it
Named on one round in the feed.
Since 2025-12-05
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
OTR Therapeutics OTR Therapeutics focuses on discovering and acquiring preclinical assets to develop innovative therapies for patients. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-12-05 | [ PART ] |